Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss Drugs

Eli Lilly and Novo Nordisk

Sensex, Nifty Edge Higher After Early Slide as Consolidation Persists

PSU bank and realty gains helped stabilize the session as attention shifts to upcoming earnings.

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves